| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Normalization, inhibition, rarefaction?
|
Morère, Jean-François
|
|
2007
|
2 |
3 |
p. 133
|
article
|
| 2 |
Radioimmunotherapy (RIT) in non-Hodgkin lymphoma
|
Kyle, Fiona
|
|
2007
|
2 |
3 |
p. 173-179
|
article
|
| 3 |
Reversible encephalopathy syndrome secondary to sunitinib for metastatic renal cell carcinoma patient
|
Medioni, Jacques
|
|
2007
|
2 |
3 |
p. 193-195
|
article
|
| 4 |
Role of the endothelins and endothelin receptors in cancer cell signaling and angiogenesis
|
Ghoul, Aïda
|
|
2007
|
2 |
3 |
p. 181-191
|
article
|
| 5 |
Simple method to detect important epidermal growth factor receptor gene mutations with bronchoscopic specimens of lung cancer patients for gefitinib treatment
|
Akagi, Kiwamu
|
|
2007
|
2 |
3 |
p. 145-151
|
article
|
| 6 |
Targeted therapy in advanced colorectal cancer, an update
|
Tol, J.
|
|
|
2 |
3 |
p. 165-172
|
article
|
| 7 |
Targeted therapy in advanced colorectal cancer, an update
|
Tol, J.
|
|
2007
|
2 |
3 |
p. 165-172
|
article
|
| 8 |
The mTOR pathway inhibitor RAD001 (everolimus) is highly efficacious in tamoxifen-sensitive and -resistant breast cancer xenografts
|
Behrens, Diana
|
|
2007
|
2 |
3 |
p. 135-144
|
article
|
| 9 |
VEGF: a key therapeutic target for the treatment of cancer-insights into its role and pharmacological inhibition
|
Tobelem, Gérard
|
|
2007
|
2 |
3 |
p. 153-164
|
article
|
Journal description